Search - tctmd.com

Displaying 141 - 160 of 1502

Sort: Relevancy | Date

Presentation ESC 2018

Outcomes of 10.312 Patients Treated with Everolimus-eluting Bioresorbable Scaffolds During Daily Clinical Practice: Results from the European Absorb Consortium

Presenter: Holger M. Nef

August 29, 2018

Presentation ESC 2018

The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX

Presenter: Marco Valgimigli

August 26, 2018

Presentation

Impact of High On-Aspirin Platelet Reactivity on Outcomes Following Successful DES Implant

August 17, 2018

Presentation CHIP Seattle 2018

Wire Across Perforation- Intact Pericardium

Presenter: Ashish Pershad

August 10, 2018

Presentation

Newer-Generation Ultrathin-Strut DES vs Older Second-Generation Thicker-Strut DES for CAD

July 11, 2018

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk –a randomized controlled single-blind multicenter trial (DEBUT)

Presentation EuroPCR 2018

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

Presenter: Tuomas Rissanen

May 26, 2018

Presentation EuroPCR 2018

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

Presenter: Andreas Baumbach

May 25, 2018

Presentation EuroPCR 2018

TIDES-ACS-Trial

Presenter: Pasi P. Karjalainen

May 25, 2018

Presentation EuroPCR 2018

Safety and performance of the resorbable magnesium scaffold, Magmaris in a real world setting - First 200 subjects at 12-month follow-up of the BIOSOLVE-IV registry

Presenter: Stefan Verheye

May 25, 2018

Presentation

12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment

May 08, 2018

Presentation Intravascular Coronary Imaging and Physiology 2018

Stent Failures -Identifying Causes of Stent Thrombosis and Restenosis and How to Fix It

Presenter: Ron Waksman

May 05, 2018

Presentation SCAI 2018

PERSPECTIVE Trial: Percutaneous Revascularization at Piedmont for Chronic Total Occlusions Survey

Presenter: David E. Kandzari

April 28, 2018

Presentation CIT 2018

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (FUTURE-I): Two-Year Clinical and Imaging Outcomes

Presenter: Bo Xu

March 23, 2018

Presentation CIT 2018

The state of evidence of high bleeding risk patients: previous and ongoing studies

Presenter: MC Morice

March 23, 2018

Presentation SCAI 2018

How to treat: Recurrent In-stent Restenosis

Presenter: Kenneth Chin

March 23, 2018

Presentation CIT 2018

Provisional Stenting For Bifurcatin Lesions

Presenter: Jean Fajadet

March 23, 2018

Presentation CIT 2018

PCI in a high bleeding risk patients

Presenter: Tullio Palmerini

March 23, 2018

Presentation ACC 2018

One-year Clinical Outcomes of the Bio-engineered COMBO stent: Primary Results from the 3614 All-comer Patients in the COMBO Collaboration

Presenter: Antonio Colombo

March 11, 2018

Presentation ACC 2018

Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study

Presenter: Ajay J. Kirtane

March 11, 2018

Presentation CHIP at ACC 2018

Update on PCI for LMCA and Multivessel Disease

Presenter: Gregg W. Stone

March 09, 2018

Advertisement

Outcomes of 10.312 Patients Treated with Everolimus-eluting Bioresorbable Scaffolds During Daily Clinical Practice: Results from the European Absorb Consortium

The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX

Impact of High On-Aspirin Platelet Reactivity on Outcomes Following Successful DES Implant

Wire Across Perforation- Intact Pericardium

Newer-Generation Ultrathin-Strut DES vs Older Second-Generation Thicker-Strut DES for CAD

Drug-eluting Balloon for the Treatment of de novo Coronary Artery Lesions in patients with high bleeding risk (DEBUT trial)

TARGET AC A prospective multicenter randomized post-market trial evaluating a novel Cobalt Chrome Rapamycin Drug Eluting Stent

TIDES-ACS-Trial

Safety and performance of the resorbable magnesium scaffold, Magmaris in a real world setting - First 200 subjects at 12-month follow-up of the BIOSOLVE-IV registry

12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment

Stent Failures -Identifying Causes of Stent Thrombosis and Restenosis and How to Fix It

PERSPECTIVE Trial: Percutaneous Revascularization at Piedmont for Chronic Total Occlusions Survey

A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients with Coronary Artery Disease (FUTURE-I): Two-Year Clinical and Imaging Outcomes

The state of evidence of high bleeding risk patients: previous and ongoing studies

How to treat: Recurrent In-stent Restenosis

Provisional Stenting For Bifurcatin Lesions

PCI in a high bleeding risk patients

One-year Clinical Outcomes of the Bio-engineered COMBO stent: Primary Results from the 3614 All-comer Patients in the COMBO Collaboration

Uptake and Utilization of Drug-Eluting Bioresorbable Vascular Scaffolds: A CathPCI Registry Study

Update on PCI for LMCA and Multivessel Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content